Pacira Pharmaceuticals, Inc. have announced results from EXCLAIM, its Phase 4 prospective, observational study to assess the use of EXPAREL for postsurgical analgesia in patients undergoing four common plastic surgery procedures.
http://www.medilexicon.com/medicalnews.php?newsid=259115
http://www.medilexicon.com/medicalnews.php?newsid=259115
No comments:
Post a Comment